Log on / register
Feedback | Support | My details
Open AccessResearch article

The frequency of CD127low expressing CD4+CD25high T regulatory cells is inversely correlated with human T lymphotrophic virus type-1 (HTLV-1) proviral load in HTLV-1-infection and HTLV-1-associated myelopathy/tropical spastic paraparesis

Jakob Michaëlsson1,5* email, Hugo Marcelo R Barbosa2* email, Kimberley A Jordan1 email, Joan M Chapman1 email, Milena KC Brunialti2 email, Walter Kleine Neto3 email, Youko Nukui3 email, Ester C Sabino3 email, Marco Antonio Chieia2 email, Acary Souza Bulle Oliveira2 email, Douglas F Nixon1 email and Esper G Kallas2,4 email

Division of Experimental Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA

Infectious Diseases Division, Federal University of São Paulo, São Paulo, Brazil

São Paulo Blood Bank, São Paulo, Brazil

Clinical Immunology and Allergy Division, University of São Paulo, Brazil

Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

author email corresponding author email* Contributed equally

BMC Immunology 2008, 9:41doi:10.1186/1471-2172-9-41

Published: 29 July 2008

Abstract

Background

CD4+CD25high regulatory T (TReg) cells modulate antigen-specific T cell responses, and can suppress anti-viral immunity. In HTLV-1 infection, a selective decrease in the function of TReg cell mediated HTLV-1-tax inhibition of FOXP3 expression has been described. The purpose of this study was to assess the frequency and phenotype of TReg cells in HTLV-1 asymptomatic carriers and in HTLV-1-associated neurological disease (HAM/TSP) patients, and to correlate with measures of T cell activation.

Results

We were able to confirm that HTLV-I drives activation, spontaneous IFNγ production, and proliferation of CD4+ T cells. We also observed a significantly lower proportion of CTLA-4+ TReg cells (CD4+CD25high T cells) in subjects with HAM/TSP patients compared to healthy controls. Ki-67 expression was negatively correlated to the frequency of CTLA-4+ TReg cells in HAM/TSP only, although Ki-67 expression was inversely correlated with the percentage of CD127low TReg cells in healthy control subjects. Finally, the proportion of CD127low TReg cells correlated inversely with HTLV-1 proviral load.

Conclusion

Taken together, the results suggest that TReg cells may be subverted in HAM/TSP patients, which could explain the marked cellular activation, spontaneous cytokine production, and proliferation of CD4+ T cells, in particular those expressing the CD25highCD127low phenotype. TReg cells represent a potential target for therapeutic intervention for patients with HTLV-1-related neurological diseases.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.